About InMed
InMed is a company based in San Diego (United States) founded in 2018 by Al Curran and Latha Poonamallee. InMed has raised $9.63 million across 4 funding rounds from investors including Exxora Trading, BIRAC and Venture Center. InMed operates in a competitive market with competitors including Viz.ai, Perspectum, Qure.ai, IXICO and Deeptek, among others.
- Headquarter San Diego, United States
- Founders Al Curran, Latha Poonamallee
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prognostics In-Med Private Limited
- Date of Incorporation 10 Jan, 2018
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$91.59 K (USD)1504.78as on Mar 31, 2021
-
Net Profit
-$128.93 K (USD)42.88as on Mar 31, 2021
-
EBITDA
-$201.83 K (USD)8as on Mar 31, 2021
-
Total Equity Funding
$9.63 M (USD)
in 4 rounds
-
Latest Funding Round
$2.13 M (USD), Seed
Dec 12, 2022
-
Investors
Exxora Trading
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of InMed
Unlock access to complete
Unlock access to complete
Scientific Team
6 people
Leadership Team
1 people
Finance and Accounting
1 people
Innovation Team
1 people
Unlock access to complete
Funding Insights of InMed
InMed has successfully raised a total of $9.63M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.13 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InMed
InMed has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Exxora Trading, BIRAC and Venture Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Business incubation services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Startups are incubated at Venture Center, backed by CSIR.
|
Locked | Locked | Locked |
Investor details for InMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InMed
Investment portfolio details for InMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InMed
Detailed financials for InMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inmed Comparisons
Peer comparison for InMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InMed
InMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viz.ai, Perspectum, Qure.ai, IXICO and Deeptek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
Detailed competitors of InMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inmed
Complete news archive for InMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InMed
InMed was founded in 2018.
InMed is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Latha Poonamallee is the current CEO of InMed. They have also founded this company.
InMed is a funded company, having raised a total of $9.63M across 4 funding rounds to date.
Annual revenue of InMed is $91.59K as on Mar 31, 2021.
Provider of AI powered medical imaging and radiology solutions. It offers FDA cleared tools for brain volumetry, workflow prioritization in trauma cases, muscle and fat quantification, and lesion detection and quantification in oncology. The tools utilize research and human centered design principles. It also develops ethnicity based reference ranges for enhanced diagnostic accuracy. Its solutions provide contextually relevant reports and actionable insights for enhanced prognostics and diagnostics. Various integration and customization options are available for deployment.
InMed's top competitors include Perspectum, Qure.ai and Deeptek.
InMed has 5 investors. Key investors include Exxora Trading, BIRAC, Venture Center, Shasta Ventures, and AET Fund.